New Long-Acting HIV Prevention Injection Approved for NHS in England and Wales
The NHS is set to offer a new long‐acting injectable therapy to prevent HIV in England and Wales, following a positive recommendation by NICE (the National Institute for Health and Care Excellence). The drug, cabotegravir (brand name Apretude), will be made available for people at risk of HIV who are unable or unwilling to take…
